February 29, 2012
FDA Approves Generic Levetiracetam Oral SolutionHi-Tech Pharmacal announced that it has received its final FDA approval for its Abbreviated New Drug Application (ANDA) for Levetiracetam oral solution 100mg/mL. Levetiracetam oral solution is the generic version of UCB Pharma's Keppra oral solution.
Hi-Tech Pharmacal's Levetiracetam oral solution is indicated for treatment of partial onset seizures in people >16 years old with epilepsy. The product is expected to be launched by May 2012.
For more information visit www.hitechpharm.com.